|1.||Mathé, Aleksander A: 2 articles (02/2015 - 07/2010)|
|2.||Cheung, Raymond Tak Fai: 2 articles (01/2005 - 11/2004)|
|3.||Chen, Shao Hua: 2 articles (01/2005 - 11/2004)|
|4.||Zohar, Joseph: 1 article (02/2015)|
|5.||Kozlovsky, Nitsan: 1 article (02/2015)|
|6.||Cohen, Hagit: 1 article (02/2015)|
|7.||Cohen, Shlomi: 1 article (02/2015)|
|8.||Matar, Michael A: 1 article (02/2015)|
|9.||Vainer, Ella: 1 article (02/2015)|
|10.||Kaplan, Zeev: 1 article (02/2015)|
11/01/2004 - "The combination of OGD and cultured neuronal cells may be useful in future studies on the neuroprotective and harmful mechanisms of NPY-Y1 receptor inhibition and activation during ischemia, respectively."
01/01/2005 - "These opposing effects of NPY-Y1 receptor activation or inhibition on nNOS and eNOS may lead to harmful or beneficial consequences following ischemia/reperfusion."
04/15/2002 - "Our results suggest that the NPY-Y1 receptor activation mediates ischemic injury via NO overproduction and that inhibition of the Y1 receptor may confer protection via suppression of excessive NO production during ischemia."
01/01/2003 - "In addition to glutamate, calcium ion and nitric oxide, activation of the neuropeptide Y-Y1 receptors may mediate cerebral damage during focal ischemia. "
|2.||Mood Disorders (Mood Disorder)
07/01/2010 - "In this study, we compared the effects of three long-term antidepressant treatments: escitalopram, voluntary running, and their combination on hippocampal cell proliferation, NPY and the NPY-Y1 receptor mRNAs, targets assumed to be important for hippocampal plasticity and mood disorders. "
|3.||Body Weight (Weight, Body)
08/01/2009 - "The neuropeptide Y(5) receptor antagonist produced greater body weight reductions in high-fat diet-fed neuropeptide Y(1) receptor knockout mice than in wild-type C57BL/6 mice. "
08/01/2009 - "Coadministration of a neuropeptide Y(1) receptor antagonist with a neuropeptide Y(5) receptor antagonist further suppressed food intake and reduced body weight. "
08/01/2009 - "A single-dose of a neuropeptide Y(1) receptor antagonist (10-30 mg/kg) suppressed spontaneous food intake and reduced body weight in high-fat diet-fed C57BL/6 mice, while treatment with a neuropeptide Y(5) receptor antagonist did not significantly reduce food intake or body weight. "
08/20/2008 - "These results provide supporting evidence that BMS-193885 reduces food intake and body weight via inhibition of the central neuropeptide Y(1) receptor. "
03/01/2001 - "Food intake inhibition and reduction in body weight gain in rats treated with GI264879A, a non-selective NPY-Y1 receptor antagonist."
|4.||Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/01/2000 - "Neuropeptide Y-Y1 receptor antisense oligodeoxynucleotide increases the infarct volume after middle cerebral artery occlusion in rats."
01/01/2003 - "Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats."
|3.||Nitric Oxide (Nitrogen Monoxide)
|5.||Nerve Growth Factor (NGF)
|6.||Glutamic Acid (Glutamate)
|7.||Transcription Factors (Transcription Factor)
|8.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|9.||Kainic Acid (Kainate)